. 2009 Jul 9;19(12):2904–2912. doi: 10.1007/s00330-009-1489-0

Table 3.

Patient characteristics in relation to MVO category (absence, disappearance and persistence)

	Early MVO
	Absent	Present
	Absent	Disappearance late MVO (−)	Persistence late MVO (+)
	(n = 31)	(n = 8)	(n = 45)	p value
Age (years)	61 ± 9	61 ± 10	59 ± 13	0.8
Male sex	22 (71)	5 (63)	34 (76)	0.7
BMI	27 ± 4	26 ± 2	27 ± 4	0.7
Smoking	26 (84)	7 (88)	41 (91)	0.6
Hypercholesterolaemia	8 (35)	2 (29)	13 (37)	0.9
Diabetes	3 (10)	0	2 (4)	0.4
Previous angina pectoris	11 (36)	2 (25)	20 (44)	0.5
Anterior localisation of MI	7 (23)	1 (13)	19 (42)	0.08
Three-vessel disease*	8 (26)	1 (13)	12 (27)	0.7
Thrombosuction	9 (29)	2 (25)	15 (33)	0.9
Time to balloon inflation (min)	232 ± 96	196 ± 80	215 ± 80	0.6
Adenosine or nitroglycerine i.c.	21 (68)	5 (63)	31 (69)	0.9
Abciximab downstream	12 (39)	5 (63)	26 (58)	0.2
Final TIMI 3 flow	27 (90)	5 (71)	41 (91)	0.3
Total CK (AUC, 1,000 h units l⁻¹)	30 ± 31^a	39 ± 14^b	73 ± 32^{a, b}	<0.001^a/0.01^b
Baseline CMR
LVEDVi (ml/m²)	81 ± 14	87 ± 17	86 ± 17	0.4
LVEF (%)	56 ± 7^c	54 ± 6	48 ± 7^c	<0.001^c
Infarct size (% LV)	6 ± 8^d	12 ± 4^e	23 ± 9^d,e	<0.001^d/0.003^e
Early MVO size (% of LV)	0^f	0.8 ± 0.4	5 ± 3.1^f	<0.001^f
Follow-up CMR
LVEDVi (ml/m²)	76 ± 17	85 ± 16	84 ± 20	0.2
LVEF (%)	59 ± 6^g	55 ± 4	51 ± 7^g	<0.001^g

Values are presented as number of patients with percentages in parentheses or mean ± standard deviation

Abbreviations: BMI body mass index, i.c. intracoronary, AUC area under the curve, LVEDVi left ventricular end-diastolic volume index, LVESVi left ventricular end-systolic volume index, LVSVi left ventricular stroke volume index, LVEF left ventricular ejection fraction, LVMi left ventricular mass index, LE late enhancement, MVO microvascular obstruction

*Stenosis greater than 70%

^a,c,d,f,gFor the difference between absence of MVO (early and late) and persistence of late MVO

^b,eFor the difference between disappearance and persistence of late MVO